Waking up to REACH*

Pharmaceuticals and life sciences survey summary

To gauge readiness and reaction to the Registration, Evaluation and Authorisation of Chemicals legislation, or REACH, PwC’s International Survey Unit interviewed 241 senior executives across 6 industries in 29 countries. Overall, we found that two in five companies have limited awareness of the regulation and one in four executives believes Europe’s complex chemicals legislation will have no impact on operations. In comparison, pharmaceuticals companies had a higher level of awareness of REACH than did other industries surveyed, though companies in North America were generally less well informed about the legislation than in Europe and Asia Pacific.